Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Cooper

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Frontiers in Endocrinology|May 9, 2022
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER StudyMarília B Gomes, Fengming Tang, Hungta Chen, et al.
Diabetes Research and Clinical Practice|February 3, 2022
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER studyAntonio Nicolucci, Hungta Chen, Andrew Cooper, et al.
The New England Journal of Medicine|April 8, 2011
Functional disability 5 years after acute respiratory distress syndromeMargaret S Herridge, Catherine M Tansey, Andrea Matté, et al.
BMJ Open Diabetes Research & Care|May 4, 2021
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER studyBrenda Bongaerts, Suzanne V Arnold, Bernard H Charbonnel, et al.
Plos One|July 30, 2013
Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphomaChristina E Wells, Srividya Bhaskara, Kristy R Stengel, et al.
The American Journal of Gastroenterology|April 20, 2016
Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal SymptomsRena Yadlapati, John E Pandolfino, Alcina K Lidder, et al.
Diabetes, Obesity & Metabolism|September 16, 2022
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER studyBernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, et al.
Pain|August 3, 2017
Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal developmentCharlie H-T Kwok, Ian M Devonshire, Amer Imraish, et al.
Diabetes Research and Clinical Practice|July 24, 2021
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER studyAntonio Nicolucci, Hungta Chen, Javier Cid-Ruzafa, et al.
Indian Heart Journal|August 4, 2022
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER studyAli O Malik, Hungta Chen, Fengming Tang, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Frontiers in Endocrinology|May 9, 2022
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER StudyMarília B Gomes, Fengming Tang, Hungta Chen, et al.
Diabetes Research and Clinical Practice|February 3, 2022
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER studyAntonio Nicolucci, Hungta Chen, Andrew Cooper, et al.
The New England Journal of Medicine|April 8, 2011
Functional disability 5 years after acute respiratory distress syndromeMargaret S Herridge, Catherine M Tansey, Andrea Matté, et al.
BMJ Open Diabetes Research & Care|May 4, 2021
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER studyBrenda Bongaerts, Suzanne V Arnold, Bernard H Charbonnel, et al.
Plos One|July 30, 2013
Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphomaChristina E Wells, Srividya Bhaskara, Kristy R Stengel, et al.
The American Journal of Gastroenterology|April 20, 2016
Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal SymptomsRena Yadlapati, John E Pandolfino, Alcina K Lidder, et al.
Diabetes, Obesity & Metabolism|September 16, 2022
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER studyBernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, et al.
Pain|August 3, 2017
Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal developmentCharlie H-T Kwok, Ian M Devonshire, Amer Imraish, et al.
Diabetes Research and Clinical Practice|July 24, 2021
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER studyAntonio Nicolucci, Hungta Chen, Javier Cid-Ruzafa, et al.
Indian Heart Journal|August 4, 2022
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER studyAli O Malik, Hungta Chen, Fengming Tang, et al.
Pageof 14